4Accepted Oct 19, 5:30 PM ET
HealthEquity, Inc.: EVP prod & strat officer Sunil sold/bought 262 shares
Accepted (ET)
5:30 PM
Oct 19, 2026
Filed
Oct 19, 2026
Documents
1
Size
10.8 KB
Summary
HealthEquity, Inc.: EVP prod & strat officer Sunil sold/bought 262 shares
What happened
- Rajasekar Sunil, EVP chief prod & strat officer, reported both sales and purchases of HealthEquity, Inc. common stock.
- Sales: 23 shares on Apr 22, 2026 at $82.81 for $1,905; 108 shares on Aug 24, 2026 at $105.60 for $11,405 (total sold 131 shares for $13,310).
- Purchases: 23 shares on Jul 8, 2026 at $95.06 for $2,186; 108 shares on Oct 15, 2026 at $90.33 for $9,756 (total bought 131 shares for $11,942).
Key details
- Transaction dates and prices:
- Apr 22, 2026 — sale 23 shares @ $82.81 for $1,905.
- Jul 8, 2026 — purchase 23 shares @ $95.06 for $2,186.
- Aug 24, 2026 — sale 108 shares @ $105.60 for $11,405.
- Oct 15, 2026 — purchase 108 shares @ $90.33 for $9,756.
- Shares owned after the transactions: not stated in the filing excerpt provided.
- Footnotes:
- F1 indicates some reported sales were short sales.
- F4 indicates some purchases represent shares delivered to cover previous short sales.
- F2 states transactions were executed in broker-managed discretionary accounts without the reporting person's knowledge and that reporting was untimely for that reason.
- F3 states the reporting person voluntarily paid approximately $1,650 to the issuer as all profits under Section 16(b) arising from these transactions.
- Timeliness: the filing notes the reporting was untimely (see F2).
Why it may matter
- The filing shows market sales and purchases and indicates short-sale activity and subsequent cover transactions.
- The filing does not show why the insider traded or why the company acted.